Dasatinib in Resectable Malignant Pleural Mesothelioma

Clinical trial NCT00652574 · COMPLETED

Trial details

NCT number: NCT00652574
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Pleural Mesothelioma

Start date: 2008-03-12
Primary completion: 2022-10-07
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.